We invite you to AAT-AD/PDTM Focus Meeting 2018, a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy and AD/PDTM.
The Conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer's, Parkinson's and other related neurological disorders.
A central theme will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PDTM 2017, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative drugs and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.
Join us 15-18 March 2018 in the historical city of Torino (Turin), the first capital of Italy and the site of the 2006 Winter Olympics at the Southern edge of the Alps.
| Ezio Giacobini, Switzerland Co-President Gabriel Gold, Switzerland Executive Organizer
| Abraham Fisher, Israel Co-President Roger M. Nitsch, Switzerland Executive Organizer Manfred Windisch, Austria Executive Organizer
|
 | This Conference is dedicated to Rita Levi-Montalcini
The Italian Nobel laureate, who was born in Torino and was honored for her work in neurobiology. In 1952 Levi-Montalcini succeeded in isolating a substance harvested from tumors in mice that caused vigorous nervous system growth in chicken embryos. The discovery of what are now known as growth factors has provided a deeper understanding of medical problems like deformities, senile dementia, delayed wound healing, and tumor diseases.
|
